- In Myeloma, Cure or Control?
Saturday, December 1st, 2018
Over the past two decades, the U.S. Food and Drug Administration (FDA) has approved a number of new treatments for patients with myeloma – most recently the anti-CD38 monoclonal antibodies – and new ways to measure disease response. This innovation has given clinicians the opportunity to redefine the goals of disease treatment and the value [...]
- How long should a multiple myeloma patient receive lenalidomide maintenance therapy?
Sunday, May 1st, 2016
This month, Sagar Lonial, MD, addresses a question about duration of maintenance therapy in a patient diagnosed with multiple myeloma.